FDA-APPROVED For Men with Erectile Dysfunction

Clinical efficacy in
difficult-to-treat patients

post-radical prostatectomy8,9*
  • For patients who underwent radical prostatectomy, STENDRA 100 and 200 mg demonstrated significant improvements vs placebo in erectile function as measured by successful penetration (SEP2), successful intercourse (SEP3), and change in mean IIEF-EF Domain Score

*STENDRA was evaluated in a 12-week, double-blind, placebo-controlled study that randomized 298 men with a history of ED of 6 months or more following bilateral nerve sparing radical prostatectomy to receive STENDRA (100 mg, 200 mg) or placebo. Men were instructed to take study drug approximately 30 minutes prior to initiation  of sexual activity. No restrictions were placed on food or alcohol intake.8,9







Savings Card